• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 3. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 4. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 5. An ionic liquid-based synergistic extraction strategy for rare earths?
  Yingbo Li,Nada Mehio,Huizhou Liu,Sheng Dai Green Chem., 2015,17, 2981-2993

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4-disubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 2,4-disubstituted thiazoles

Professional Introduction to 2-methyl-4-(propan-2-yl)-1,3-thiazole (CAS No. 32272-52-9)

2-methyl-4-(propan-2-yl)-1,3-thiazole, identified by its Chemical Abstracts Service (CAS) number 32272-52-9, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic synthesis. This compound belongs to the thiazole class, a heterocyclic structure characterized by a sulfur atom and a nitrogen atom in its five-membered ring. The presence of alkyl substituents at the 2nd and 4th positions, specifically a methyl group and an isopropyl group, enhances its chemical reactivity and functional versatility, making it a valuable intermediate in the synthesis of more complex molecules.

The thiazole core is a pharmacophore found in numerous bioactive natural products and synthetic drugs, contributing to its broad utility in medicinal chemistry. Its unique electronic properties stem from the conjugation between the sulfur and nitrogen atoms, which allows for diverse interactions with biological targets. Recent advancements in computational chemistry have enabled more precise modeling of 2-methyl-4-(propan-2-yl)-1,3-thiazole, revealing potential applications in drug design and development.

In recent years, researchers have explored the pharmacological properties of derivatives of 1,3-thiazole, including 2-methyl-4-(propan-2-yl)-1,3-thiazole. Studies have demonstrated that modifications to the thiazole ring can modulate its biological activity, leading to compounds with antimicrobial, anti-inflammatory, and anticancer effects. For instance, derivatives of this scaffold have been investigated for their ability to inhibit enzymes involved in cancer cell proliferation and metabolic pathways relevant to neurodegenerative diseases.

The synthesis of 2-methyl-4-(propan-2-yl)-1,3-thiazole typically involves multi-step organic reactions, often starting from commercially available precursors such as thioamides or ketones. The introduction of the isopropyl group at the 4th position requires careful control of reaction conditions to ensure high yield and purity. Advances in catalytic methods have improved the efficiency of these synthetic routes, making large-scale production more feasible for research and industrial applications.

One of the most compelling aspects of 2-methyl-4-(propan-2-yl)-1,3-thiazole is its role as a building block in medicinal chemistry. Its structural features allow for facile functionalization at multiple sites, enabling the creation of libraries of derivatives with tailored biological activities. High-throughput screening techniques combined with machine learning models have accelerated the discovery process by predicting potential hits based on structural similarities to known active compounds.

Recent studies have highlighted the importance of thiazole derivatives in addressing emerging therapeutic challenges. For example, modifications to the methyl and isopropyl substituents have been optimized to enhance binding affinity to target proteins. This has led to the identification of novel compounds with improved pharmacokinetic profiles and reduced toxicity compared to earlier analogs.

The chemical stability of 2-methyl-4-(propan-2-yl)-1,3-thiazole under various conditions has also been thoroughly investigated. Researchers have found that protective groups can be employed during synthetic transformations to prevent unwanted side reactions while maintaining functional integrity. This has opened up new possibilities for incorporating thiazole-based motifs into more complex drug candidates without compromising their efficacy.

In conclusion, 2-methyl-4-(propan-2-yl)-1,3-thiazole (CAS No. 32272-52-9) represents a promising scaffold for pharmaceutical innovation. Its unique structural features combined with recent advances in synthetic methodologies make it an attractive candidate for further exploration in drug discovery programs. As our understanding of biological pathways continues to expand, thiazole derivatives like this compound will play an increasingly important role in developing treatments for a wide range of diseases.

• 15679-11-5(4-TERT-BUTYL-2-METHYLTHIAZOLE)
• 184839-20-1((4-Tert-butyl-1,3-thiazol-2-yl)methylamine Dihydrochloride)
• 184154-42-5(4-(propan-2-yl)-1,3-thiazole-2-carbaldehyde)
• 156589-83-2(2-Thiazolemethanol,4-(1-methylethyl)-)
• 644950-38-9(2-Thiazolemethanamine,N-methyl-4-(1-methylethyl)-)
• 643725-72-8(4-(propan-2-yl)-1,3-thiazol-2-ylmethanamine)
• 149168-07-0(Thiazole, 2-(bromomethyl)-4-(1-methylethyl)-)
• 128312-58-3(Thiazole, 4-cyclopropyl-2-methyl-)
• 32272-48-3(Thiazole,4-ethyl-2-methyl-)
• 184154-45-8(Thiazole,2-ethynyl-4-(1-methylethyl)-)